See also this year's filing and all EDGAR filings for this company.
PDF Report 0000811641_2025_Immucell_CORP_DE.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0000811641, Immucell CORP DE
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 13,170,077 |
| 1 | LiabilitiesCurrent | 4,412,213 |
| 2 | remainder_Liabilities | 0 |
| 3 | AssetsCurrent | 15,042,750 |
| 4 | AssetsNoncurrent | 4,594,047 |
| 5 | PropertyPlantAndEquipmentNet | 25,349,019 |
| 6 | Goodwill | 114,661 |
| 7 | remainder_Assets | 0 |
| 8 | GeneralAndAdministrativeExpense | 24,234,746 |
| 9 | ResearchAndDevelopmentExpense | 3,898,582 |
| 10 | remainder_Expenses | 10,056 |
| 11 | remainder_Revenues | 26,493,169 |
| 12 | remainder_NetIncome | -506,414 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 17,582,290 |
| 1 | Assets | 45,100,477 |
| 2 | Expenses | 28,143,384 |
| 3 | Revenues | 26,493,169 |
| 4 | StockholdersEquity | 27,518,187 |
| 5 | NetIncome | -2,156,629 |
| 6 | ComprehensiveNetIncome | -2,156,629 |
| 7 | BaseVar | 58,912,867 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.13 |
| 9 | EconomicCapitalRatio | 1.77 |